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ABSTRACT 
To monitor antimicrobial resistance in zoonotic and indicator bacteria from food-producing animal populations 
and meat thereof under Decision 2013/652/EC, a guidance for randomised sampling procedures is provided. 
Prospective  and  retrospective  sampling  plans  for  samples  and  isolates  are  addressed.  The  former  involves 
collecting sufficient numbers of representative animal and food samples from which recovered isolates are tested 
for susceptibility; the latter involves selecting randomly Salmonella isolates from collections constituted within 
the framework of either the national control programmes in poultry flocks or from verification of the compliance 
with  process  hygiene  criterion  in  broiler  carcases.  A  generic  proportionate  stratified  sampling  process  is 
proposed and numerical illustrations of proportional allocation are provided. Stratified sampling of Salmonella 
isolates from poultry primary productions is performed with proportional allocation to the size of the isolate 
collections available in the official laboratories. An alternative approach would be a simple random sampling 
within the sampling frame of flocks positive for Salmonella. Stratified sampling of caecal samples, accounting 
for at least 60 % of the domestic production of food-producing animal populations monitored, with proportionate 
allocation to the slaughterhouse production, allows for the collection of representative isolates of Campylobacter 
and indicator E. coli and enterococci in various animal populations. Stratified sampling of Salmonella isolates 
from broiler carcases is proposed with proportional allocation to the size of the isolate collections available in the 
official laboratories involved in verifying the compliance with the Salmonella process hygiene criterion. These 
isolates may be complemented with those recovered by the food business operator. Sampling of different chilled 
fresh meat categories is targeted at retail outlets serving the final consumer, with proportional allocation of the 
number  of  samples  to  the  population  of  geographical  areas  accounting  for  at  least  80 %  of  the  national 
population, to test for the presence of ESBL-/AmpC-/carbapenemase-producing E. Coli.   
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SUMMARY 
In accordance with Directive 2003/99/EC on monitoring of zoonoses and zoonotic agents, Member 
States  must  ensure  that  monitoring  provides  comparable  data  on  the  occurrence  of  antimicrobial 
resistance (AMR) in zoonotic agents. Also foreseen is the possibility of broadening the scope of the 
antimicrobial resistance monitoring to other zoonotic agents in so far as they present a threat to public 
health.  The  Commission  Implementing  Decision  2013/652/EC  lays  down  specific  technical 
requirements  for  AMR  testing  and  reporting  in  representative  isolates  deriving  from  randomised 
sampling  of  broilers,  laying  hens,  fattening  turkeys,  fattening  pigs  and  calves,  performed  at  farm 
and/or at slaughter, and of meat from broilers, pork and beef performed at retail.  
The European Food Safety Authority received a mandate from the European Commission to provide 
recommendations on harmonised randomisation procedures for AMR monitoring pursuant to Decision 
2013/652/EC.  This  scientific  report  provides  a  rationale  and  harmonised  practical  procedures  for 
randomised  sampling  of  animal  and  meat  samples  at  different  stages  of  the  food  chain,  yielding 
representative  and  comparable  data.  Two  different  collection  strategies,  a  prospective  and  a 
retrospective sampling plan, of samples and isolates, respectively, are foreseen. The former involves 
collecting sufficient numbers of representative animal and chilled meat samples from which recovered 
isolates are tested for susceptibility; the latter involves selecting randomly Salmonella isolates from 
collections constituted within the framework of either the national control programmes of Salmonella 
in poultry flocks or from verification of the compliance with the Salmonella process hygiene criterion 
in broiler carcases. A generic proportionate stratified sampling process is proposed for the different 
sampling plans and numerical illustrations of proportional allocation are also provided. 
Stratified sampling of Salmonella isolates recovered from broiler, laying hen and fattening turkey 
primary productions, and available in the collection of the laboratories involved in the Salmonella 
national control programmes, with proportional allocation to the size of the collection  of isolates 
recovered from the production, is proposed. An alternative approach is to perform a simple random 
sampling within the sampling frame of flocks positive for Salmonella in those MS where a database 
records flocks tested positive for Salmonella. One Salmonella isolate per serovar and epidemiological 
unit should be retained for susceptibility testing. 
Stratified sampling of caecal content samples (single or pooled) in the slaughterhouses, accounting for 
at least 60 % of the domestic production of the food-producing animal populations monitored, with 
proportionate allocation to the slaughterhouse production, allows for the collection of representative 
isolates of Campylobacter, indicator E. coli and enterococci from the populations of broilers, fattening 
turkeys, fattening pigs and calves of less than one year of age, domestically produced. Definitions of 
‘domestically produced’ animals are proposed for the sake of harmonisation. 
Stratified  sampling  of  Salmonella  isolates  from  broiler  carcases  is  proposed  with  proportional 
allocation to the size of the isolate collections available in the laboratories involved in testing for 
verification of compliance with the Salmonella process hygiene criterion by the competent authority. 
These isolates may be complemented with those isolates recovered by the food business operators 
within the same framework.  
Sampling  of  different  chilled  fresh  meat  categories  is  targeted  at  retail  outlets  serving  the  final 
consumer, with proportional allocation of the number of samples to the population of the geographical 
region (NUTS-3 area) accounting for at least 80 % of the national population, to test for the presence 
of ESBL-/AmpC-/carbapenemase-producing E. coli.  
In addition, it is emphasised that if complementary AMR monitoring in additional animal populations 
and food categories is carried out, specific representative sampling plans should be devised and results 
should be reported separately. Finally, it is proposed that the technical specifications be re-assessed 
and updated regularly in the light of the results of the first monitoring campaigns and the most recent 
literature. Technical specifications on randomised sampling for AMR monitoring 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION
4 
In accordance with Directive 2003/99/EC on monitoring of zoonoses and zoonotic agents Member 
States must ensure that monitoring provides comparable data on the occurrence of AMR in zoonotic 
agents and, in so far as they present a threat to public health, other agents. In particular, Member 
States  must  ensure  that  the  monitoring  provides  relevant  information  at  least  with  regard  to  a 
representative number of isolates of Salmonella spp., Campylobacter jejuni and Campylobacter coli 
from cattle, pigs and poultry and food of animal origin derived from these populations. 
The Commission has prepared a Commission Implementing Decision
5 on harmonised monitoring of 
antimicrobial resistance in zoonotic and commensal bacteria. The Decision is based on the Scientific 
Report of EFSA on  ‘Technical  specifications  on  the  harmonised  monitoring  and  reporting  of 
antimicrobial  resistance  in  Salmonella,  Campylobacter  and  indicator  Escherichia  coli  and 
Enterococcus spp. bacteria transmitted through food’
6. 
The Decision
4 has been applied from 1 January 2014 for monitoring poultry populations and will be 
applicable from 1 January 2015 for monitoring pigs and calves. Apart from AMR monitoring of 
Salmonella  isolates  from  poultry  flocks,  obtained  within  the  framework  of  national  control 
programmes in accordance with Article 5 of Regulation (EC) No 2160/2003
7, the legislation also lays 
down the requirements for AMR testing in isolates from a randomised sampling of: 
  Carcases  of  broilers,  fattening  turkeys,  pigs  and  calves  under  one  year  at  slaughter  for 
Salmonella; 
  Caeca of broilers and fattening turkeys at slaughter for Campylobacter, indicator commensal 
Escherichia coli and ESBL- or AmpC- or carbapenemase producing E. coli;  
  Caeca of pigs and calves under one year at slaughter for indicator commensal and ESBL- or 
AmpC- or carbapenemase producing E. coli;  
  Fresh  meat  from  poultry,  pig  and  cattle  collected  at  retail  for  ESBL-  or  AmpC-  or 
carbapenemase-producing E. coli; 
Recommendations  on  randomisation  to  be  included  in  a  sampling  design  have  been  included  in 
several EFSA reports with technical specifications for previous baseline surveys e.g. for a survey on 
Listeria monocytogenes in selected categories of ready-to-eat food at retail
8. 
During discussions with the Member States, and with a view to obtaining high quality data from the 
monitoring, further recommendations on a randomisation of the sampling were requested from EFSA 
as it would be beneficial for Member States  to have scientific and technical assistance from EFSA, 
proposing harmonised randomisation procedures for AMR monitoring.  
                                                       
4  The mandate of the European Commission was received before the publication of Decision 2160/2013 and therefore, this 
background has been adapted to account for the legal provisions eventually adopted. 
5  Commission Implementing Decision of 12 November 2013 on the monitoring and reporting of antimicrobial resistance in 
zoonotic and commensal bacteria (OJ L 303, 14.11. 2013, p. 26). 
6  EFSA Journal 2012; 10(6):2742. 
7  Regulation (EC) No 2160/2003 of the European Parliament and of the Council of 17 November 2003 on the control of 
Salmonella and other specified food-borne agents (OJ L 325, 12.12.2003, p. 1). 
8  The EFSA Journal, (2009), 300, 1-66. Technical specifications on randomised sampling for AMR monitoring 
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TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In  accordance  with  Article  31  of  Regulation  (EC)  No  178/2002,  EFSA  is  requested  to  provide 
scientific  and  technical  assistance  proposing  harmonised  randomisation  procedures  for  AMR 
monitoring in samples collected at different stages of the food production chain. In particular EFSA 
should provide practical guidance for risk managers in the different Member States for the planning of 
monitoring programs based on randomised sampling design:  
As regards poultry: 
1.  in slaughterhouses for sampling of carcases and caeca of both broilers and fattening turkeys. 
Caecal sampling in turkeys is only required in a Member State if more than 10 000 tonnes turkey 
meat produced per year. 
2.  at retail on fresh broiler meat. 
As regards pigs and bovine animals: 
3.  in slaughterhouses for sampling of carcases and caeca of both slaughter pigs and calves under 
one  year  of  age.  Sampling  in  calves  is  only  required  in  a  Member  State  if  more  than 
10 000 tonnes of calf meat is produced per year. 
3.  at retail on fresh meat of pigs and beef. 
CONTEXT OF THE SCIENTIFIC OUTPUT 
A Commission Implementing Decision has been applied from 1 January 2014 for monitoring poultry 
populations and will be applicable from 1 January 2015 for monitoring pigs and calves (over one year 
of age). This decision lays down the requirements for AMR testing in isolates from a randomised 
sampling of broilers, pigs, calves, at retail and broilers, turkeys, pigs and calves at slaughter. This 
document provides practical guidance for risk managers for the planning of AMR monitoring.  
 Technical specifications on randomised sampling for AMR monitoring 
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TECHNICAL SPECIFICATIONS 
1.  Introduction 
In  the  European  Union  (EU),  antimicrobial  resistance  (AMR)  in  bacteria  from  food-producing 
animals, and food thereof, is monitored pursuant to obligations  under Directive 2003/99/EC
9
  and 
secondary legislation. The Directive obliges Member States (MS) to monitor and report on AMR in 
zoonotic agents, such as Salmonella and Campylobacter, in poultry, pigs and cattle, and food of 
animal  origin  derived  from  those  animals. The  monitoring  must  provide comparable  data  on  the 
occurrence of AMR derived from the investigation of a representative number of isolates as well as 
relevant complementary information on the monitoring system in place. MS shall assess trends and 
sources of zoonotic agents and AMR in their territory. Also foreseen is the possibility of broadening 
the scope of AMR monitoring to other agents in so far as they present a threat to public health. In 
addition, MS shall monitor sources of these agents and outbreaks in their territory, and assess trends, 
and transmit to the European Commission (EC) a report covering the data collected every year. The 
data transmitted under Directive 2003/99/EC relate to the occurrence of zoonotic agents isolated from 
animals, food and feed, as well as to antimicrobial resistance in these agents. 
The European Food Safety Authority (EFSA) received a mandate from the European Commission to 
assess  whether,  in  light  of  the  experience  accrued  with  the  production  of  the  European  Union 
Summary  Reports  on  Antimicrobial  Resistance,  the latest  scientific opinions  issued  by  EFSA  on 
antimicrobial resistance, and the efforts to increase the comparability between the findings from the 
food and animal sector with those gathered from humans, there was need to revise previous technical 
specifications issued by EFSA (EFSA, 2007, 2008). For this purpose, EFSA issued one scientific 
report providing technical specifications on harmonised monitoring and reporting of antimicrobial 
resistance  in  Salmonella,  Campylobacter  and  indicator  Escherichia  coli  and  Enterococcus  spp. 
bacteria  transmitted  through  food  (EFSA,  2012).  Some  key  technical  requisites  foreseen  by  the 
Commission Implementing Decision 2013/652/EC
10 were derived from this scientific report issued by 
EFSA in 2012.  
Indeed, general requirements on the monitoring and r eporting of AMR in zoonotic and commensal 
bacteria are laid down in  the Commission Implementing Decision 2013/652/EU; notably, technical 
requirements regarding the sampling framework, including indications on the origin of the isolates, 
the sampling freque ncy, the sample size and the sample collection. General indications on the 
laboratory analytical methods for antimicrobial susceptibility testing and data reporting are also 
provided in the same legislation. 
Nevertheless,  it  became  apparent,  during  the  leg islative  procedure,  that  there  was  a  need  for 
harmonised randomisation procedures for AMR monitoring in samples collected at different stages of 
the food production chain. Therefore the EC issued a specific mandate to EFSA to provide practical 
guidance for risk managers, in the different MS, for the planning of AMR monitoring program mes 
based on randomised sampling designs foreseen by Decision 2013/652/EC. The national competent 
authority (NCA) is responsible for ensuring the randomisation of the sampling scheme and its correct 
implementation. 
This scientific report provides a rationale and harmonised procedures for randomised sampling for 
monitoring AMR yielding comparable data. Some proposals made in this report reinforce a number of 
recommendations already made elsewhere. 
                                                       
9  Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the monitoring of zoonoses 
and zoonotic agents, amending Council Decision 90/424/EEC and repealing Council Directive 92/117/EEC. OJ L 325, 
12.12.2003, p. 31-40. 
10   Commission Implementing Decision 2013/652/EU of 12 November 2013 on the monitoring and reporting of antimicrobial 
resistance in zonotic and commensal bacteria. OJ L 303, 14.11.2033, p. 26-39.  Technical specifications on randomised sampling for AMR monitoring 
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2.  Rationale for the choice of the randomised sampling strategies and procedures 
2.1.  Representative randomised sampling 
The quality of data used in producing various statistics is crucial to ensuring dissemination of reliable 
information. Risk assessment and situation monitoring should be based on quality information. Data 
quality  may  be  generally  defined  from  several  dimensions,  such  as  accuracy,  availability, 
completeness,  relevance,  reliability,  timeliness  and  validity.  Although  it  is  desirable  that  all 
dimensions  are  addressed,  a  trade-off  usually  has  to  be  made  between  these  quality  aspects;  the 
decision  is  often  driven  by  the  intended  purpose  of  the  data  collected.  In  general,  data 
representativeness refers to a phenomenon where the data collected (typically derived from a sample) 
reflect  the  population  under  study  accurately.  Ramsey  and  Hewitt  (2005)  note  that  this  is  only 
possible after deciding upon the quality aspects to be taken into account and clearly stipulating the 
purpose of collecting data. 
Sampling design for survey/routine monitoring entails all the processes concerned with obtaining 
descriptive  or inferential  statistics  of  the  population  of  interest  by  studying just  a portion  of the 
population instead of the whole population (Kish, 1965; Kalton, 1983). Compared to studying the 
whole population (census), a survey has several advantages such as cost-effectiveness, as studying the 
whole population requires more financial and human resources than concentrating just on a part of it. 
Furthermore, sample survey/routine monitoring requires less time than census monitoring; hence, the 
required  statistics  are  likely  to  be  obtained  more  quickly  when  these  data  are  still  relevant. 
Importantly, it is not always feasible to study the whole population. However, the survey/routine 
monitoring should be designed in accordance with scientific guidelines to help control some of the 
errors that may arise due to studying part of the population instead of the whole population (Stopher 
and Meyburg, 1979). 
The guidelines are a collection of interrelated recommendations on factors, such as type of data, 
methods of data collection, data processing and sample design (Kalton, 1983). It is vital that every 
step is planned with the aim of designing a monitoring sample that is representative of the population 
under  study.  Indeed,  randomised  sampling  strategies  allow  for  proper  statistical  data  analysis 
including reduction of the effect of sampling bias. It is particularly important that the bacterial isolates 
originate from healthy animals sampled from randomly selected holdings or flocks or are randomly 
selected within the slaughterhouses. A random sample in animal population/food category targeted 
ensures the representativeness of the entire population, and reflects possible variability in managerial 
and hygienic practices in holdings and in different country regions. An important stage in designing a 
sample  survey  is  a  clear  definition  of  the  targeted  population,  and  the  elements,  i.e.  the 
epidemiological units that make up the population under study from which information is sought.  
2.2.  Animal populations and meat thereof under study 
Focusing on the animal populations from which the consumer will most likely be exposed through 
food thereof, in particular meat, corresponds to various production types of the main food-producing 
animal populations, such as broilers, laying hens, fattening turkeys, fattening pigs, calves, and meat 
from broilers, fattening pigs and bovine meat. Indeed, in order to obtain more informative, consistent 
and comparable results, sampling is performed at the level of differing animal populations, accounting 
for extremely diverse farming practices, including various antimicrobial treatment regimes that are in 
use in the different production types. 
An important aim of AMR monitoring is to collect resistance data that could be combined with those 
on exposure to antimicrobials. For this purpose, AMR monitoring should primarily focus on domestic 
production, so that the putative relationships between antimicrobial resistance and antimicrobial usage 
can be analysed. The animals domestically produced may be broadly defined as those born and raised 
in the country of slaughter as well as those born abroad but raised in the MS over a period of time 
during which they may have been exposed to antimicrobial treatments e.g. starting from the first week Technical specifications on randomised sampling for AMR monitoring 
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of  life  for  poultry.  In  addition,  AMR  monitoring  should  be  performed  in  healthy  animals; 
antimicrobial  susceptibility  results  deriving  from  diseased  animals  or  obtained  from  clinical 
investigations should be reported separately. 
Monitoring  AMR  in  meat,  in  particular  when  sampled  at  retail,  provides  a  first  insight  into 
consumers’ exposure to resistant bacteria, although it should be borne in mind that food preparation 
may have an impact on the bacterial load of food eaten by the final consumer.  
2.3.  Sampling time 
An even distribution of the collected samples over the year enables all seasons to be covered. For 
practical reasons, and to allow for more flexibility in implementing sampling plans, it is proposed to 
construct the generic proportional allocation in quarters rather than months, although this approach 
does  not  hamper  performing  the  randomised  sampling  on  a  monthly  basis,  in  particular  where 
specified by the legislation. 
2.4.  Selection strategy 
According to Decision 2013/652/EU, samples/isolates should be collected according to two different 
selection strategies, ‘prospective sampling’ and ‘retrospective sampling’.  
2.4.1.  Prospective sampling 
Prospective  sampling  allows  for  active  monitoring  of  AMR  in  bacteria  isolated  from  (1)  caecal 
samples  of  broilers,  fattening  turkeys,  fattening  pigs  and  bovines  under  one  year  of  age  at  the 
slaughterhouse,  and  (2)  samples  of  fresh  broiler  meat,  pig  meat  and  bovine  meat  at  retail.  The 
representative  sampling  of  caecal  samples  performed  at  the  slaughterhouse  is  emphasised,  as  it 
increases the chance of obtaining bacterial isolates and is a cost-effective way to collect samples in 
most  of  the MS.  In  the  case  of  prospective  sampling,  it  is  expected that  MS  plan in  advance a 
sampling plan covering the whole year (or most of it) in accordance with the guidelines provided in 
this report, so that a sufficient number of representative samples is collected evenly throughout the 
year  to  eventually  obtain the  numbers  of  isolates  required  by  the  legislation  (e.g.  samples  to  be 
collected equally split by quarters of the year). 
2.4.2.  Retrospective sampling 
Retrospective sampling allows for active monitoring of AMR in Salmonella spp. Isolates obtained 
from  (1)  census  sampling  of  laying  hen,  broiler  and  fattening  turkey  flocks,  sampled  within  the 
framework  of  the  national  control  programmes  (NCP)  (as  foreseen  by  Regulation  (EC)  No 
2160/2003
11) and (2) representative sampling of carcasses of broilers, fattening turkeys, fattening pigs 
and bovines under one year of age at  slaughterhouse, sampled by the Competent Authority (CA) 
and/or, if needed, food business operators (FBO) in order to verify compliance with  process hygiene 
criteria (as foreseen by Regulation (EC) No 2073/2005
12). 
In the case of retrospective sampling, advantage is taken of Salmonella spp. Isolate collections already 
available from the CA and/or FBOs. In this case, MS are, therefore, not expected to prepare an 
additional  sampling  campaign,  but  rather  to  apply  the  guidelines  provided  in  this  report  to 
retrospectively select representative isolates among the ones already available. This should be done at 
regular intervals during the year (e.g. quarters), so to ensure an even distribution throughout the year 
of the isolates tested for susceptibility to antimicrobials. 
                                                       
11   Regulation (EC) No 2160/2003 of the European Parliament and of the Council of 17 November 2003 on the control of 
salmonella and other specified food-borne zoonotic agents. OJ L 325, 12.12.2003, p. 1-15. 
12   Commission Regulation (EC) No 2073/2005 of 15 November 2005 on microbiological criteria for foodstuffs. OJ L 338, 
22.12.2005, p. 1-26. Technical specifications on randomised sampling for AMR monitoring 
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3.  Generic proportionate stratified sampling approach 
3.1.  Generic stratified sampling approach and sampling plans 
The simple and robust randomised sampling procedure proposed in these technical specifications is a 
compromise between ‘good statistical practices’ and practical issues, mostly relying on a stratified 
sampling approach with proportional allocation of the sample numbers per strata. Stratified sampling 
is  a  method  of  sampling  from  a  population  which  involves,  in  the  first  step,  the  division  of  a 
population into smaller groups known as strata. The strata are formed based on members’ shared 
attributes or characteristics. In the second step, a random sample from each stratum is taken in a 
number proportional to the stratum’s size when compared to the population. These subsets of the 
strata are then pooled to form a random sample. In practice, stratified random sampling is typically 
employed in large-scale surveys/routine monitoring to reduce some of the logistical costs associated 
with collecting information from a sample.  
The general characteristics of the proportional stratified sampling approach, applied to the prospective 
sampling  plans  of  samples  and  the  retrospective  sampling  plans  of  isolates,  as  foreseen  by  the 
Commission Implementing Decision 2013/652/EU, are briefly presented in Table 1. It gives a first 
insight into the application of stratified sampling concepts, such as strata, proportional allocation, 
epidemiological unit, to the sampling plans requested by the legislation. More detailed indications 
about every specific sampling plan are provided in Sections 4, 5, 6 and 7 of this report. Technical specifications on randomised sampling for AMR monitoring
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Table 1:   General  characteristics  of  the  stratified  sampling  approach  applied  to  prospective 
sampling  of  samples  and  retrospective  sampling  of  isolates  as  foreseen  by  the  Commission 
Implementing Decision 2013/652/EU. 
  Prospective sampling of samples   Retrospective sampling of isolates 
 
Sampling of caecal 
samples at slaughter 
Sampling of meat 
samples at retail 
 Sampling of Salmonella 
isolates from primary 
production of poultry
 (d) 
Sampling of Salmonella 
isolates from carcasses 
Target 
populations 
Domestically produced 
- Broilers
(a) 
- Fattening Turkeys
(a) 
- Fattening Pigs
(a) 
- Bovines <1 year
(a) 
- Broiler meat 
- Pig meat 
- Bovine meat 
 
- Broiler flocks 
- Laying hen flocks 
- Fattening turkey flocks 
- Broilers 
- Fattening Turkeys 
- Fattening Pigs 
- Bovines <1 year 
Strata (1
st stage)   Slaughterhouses
 (b)   NUTS-3 area 
(c)   Laboratories involved in 
NCPs 
Laboratories involved in 
isolation of Salmonella 
Proportional 
allocation  
Sample size 
proportionate to the 
slaughterhouse 
throughput 
Sample size 
proportionate to the 
NUTS-3 area 
population 
 Isolate sample size pro-
portionate to the size 
of the relevant
 (e) isolate col-
lection in the laboratory
 (f) 
Isolate sample size pro-
portionate to the size of 
the relevant
 (e) isolate col-
lection in the laboratory 
2
nd stage  
Batches/lots of 
carcases originating 
from the sample 
flock/herd 
Retailers 
 
NA  NA 
Epidemiological Unit  Flock of poultry or 
herd of pigs/bovines  One lot of meat   Flock of poultry  Slaughter batch 
Sample/Isolate  
1 sample of caecal 
content per 
epidemiological unit
 (g) 
1 meat sample 
per lot 
 1 isolate per flock 
of poultry 
1 isolate per batch 
of carcases 
NA: non applicable. 
(a):  The  source  population  of  broilers/fattening  turkeys/fattening  pigs/bovines  of  less  than  1  year  of  age  covers  that 
domestically produced and slaughtered in the slaughterhouses representing at least 60 % of the all broilers/fattening 
turkeys/fattening pigs/bovines of less than 1 year of age slaughtered in the Member State.  
(b):  Those plants that accounted for at least 60 % of all broilers/fattening turkeys/fattening pigs/bovines of less than 1 year 
of age domestically produced in the previous year. 
(c):  Those NUTS-3 areas that accounted for at least 80 % of the national population according to the most recent statistics, 
as a logistic compromise. 
(d):  SRS performed in the sampling frame of the poultry flocks tested positive for Salmonella is also alternatively proposed 
in the MS where a (central) database continuously records newly detected positive flocks (see Section 4.3.2). 
(e):  The size of the relevant isolate collection is the number of isolates originating from the examined animal population in 
the study period. 
(f):   Those laboratories accounting for 80 % of the total number of Salmonella isolates in the poultry production in question 
within the MS in the previous year, as a logistic compromise, where the Salmonella prevalence is important. 
(g):  The sample of caecal content may derive from one carcase (single sample) or a number of carcases (pooled sample) per 
batch/lot  of  carcases  originating  from  the  same  epidemiological  unit,  whether  a  flock  of  poultry  or  a  herd  of 
pigs/bovines. 
 Technical specifications on randomised sampling for AMR monitoring 
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3.2.  Generic stratified sampling process 
The process of stratified sampling for a particular sampling plan in a given MS is depicted in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a): The strata for which cumulative proportion is larger than 0.6 but smaller than 0.7 /larger than 0.8 but smaller than 0.9 are 
selected, respectively. 
Figure 1:   Flowchart presenting the generic process of stratified sampling 
  The allocation proportion will be 
further inflated, where necessary, to 
account for: 
-  Prevalence of the bacteria; 
-  Recovery rate after storage. 
Final adjustments and SRS 
   The allocation proportion per 
stratum will be then further 
inflated by 5 % to account 
for possible missingness 
(missing data) and further 
multiplied by the number of 
samples to take during a 
year (e.g. 170) divided by 4. 
Samples per Quarter     The proportion of samples 
per strata will be based on 
the ratio between 
capacity/inhabitants from 
selected stratum and their 
subtotal. 
Allocation Proportion 
Member State 
   Listing all elements. 
   Collecting most recent 
information regarding 
capacity/inhabitants. 
All Strata 
   Sorting the strata by 
capacity/inhabitants. 
   Calculate the ratio between 
capacity/inhabitants and total 
capacity/inhabitants in the MS. 
   Calculate cumulative proportion for 
sorted epidemiological units. 
   Select at least those strata ensuring 
representation of 60 %/80 % 
(a) of 
the population. 
Selection of Strata Technical specifications on randomised sampling for AMR monitoring 
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3.2.1.  Identification and selection of strata 
Once  the  targeted  population  and  the  elements  of  the  sampling  procedure,  such  as  strata  and 
epidemiological units (EpiU), have been identified, the number of strata from which to sample (K) is 
subsequently selected according to the ‘capacity’ of the stratum. Depending on the sampling plan 
considered, the ‘capacity’ of the stratum may be (1) the annual throughput of the slaughterhouse in the 
previous year, (2) the number of inhabitants in the NUTS-3 region, (3) number of relevant isolates 
obtained  in  the  previous  year  and  stored  in  the  isolate  collection  of  the  laboratory  in  a  MS 
representing 60 %/80 % of the total throughput, inhabitants or isolates collected in the MS once sorted 
by their capacity for the case of slaughterhouse or laboratories or inhabitants in the different regions. 
3.2.2.  Proportional allocation of sample size per strata and per quarter 
Next to the selection of the strata from which to sample, the number of isolates/samples to be taken 
for each stratum will be proportional to the throughput, inhabitants, or previous isolates collected in 
the laboratories, considering the total number of isolates/samples to be collected in a year divided into 
four quarters, further assuming 5 % of potential missingness (missing data), the required number of 
isolates/samples per stratum should be inflated 5 % in order to achieve the appropriate number of 
isolates/samples and power. In the case where the number of isolates/samples to be sampled is N, then 
the number of isolates/samples to be sampled by quarter for each stratum will be calculated as N 
divided by 4, further multiplied by 1.05 and then multiplied by the allocation proportion previously 
described ( K . Epi . N X ). 
To account for issues that may be encountered in a number of special cases,  scenarios have been 
developed and are illustrated numerically to guide the process of proportional allocation as shown 
below,  always  considering  simple  random  sampling  within  each  of  the  strata.  These  numerical 
illustrations of proportional allocation are performed considering that: 
  the total number of samples/isolates to be collected in a year equals 170 and thus, the number 
of  samples  to  be  collected  per  quarter  (without  considering  any  potential  missingness 
(missing data) should therefore equal at least 43; 
  the sampling plan focus on those strata ensuring a representation of at least 60 %
13 of the 
population (cumulative proportion is larger than 0.6 but smaller than 0.7), as it is foreseen by the 
legislation for the sampling of caecal samples at the slaughterhouse.  
Nevertheless, while calculating the number of caecal samples to be taken at slaughter, it is advisable 
to account for the prevalence of the zoonotic bacteria and any potential missingness{missing data}.  
3.2.2.1.  Scenario I 
Under Scenario I, it is considered that the number of isolates/samples available/collected per quarter 
in each of the selected strata ( K . Epi . N Y ) is larger than the allocated number of isolates/samples to be 
sampled ( K . Epi . N X ). 
                                                       
13   In the case where the plan should ensure a representation of at least 80 % of the population, the numerical calculation 
should be adapted accordingly. Technical specifications on randomised sampling for AMR monitoring 
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Table 2:   Numerical illustration of proportional allocation under scenario I 
(a),(b),(c). 
MS  Strata  Stratum 
capacity  Proportion  Cumulative 
proportion 
Allocation 
proportion 
(
K . Epi . N ) 
Samples per 
quarter 
(
K . Epi . N X ) 
Sample unit 
available 
(
K . Epi . N Y ) 
Samples 
taken
(c)
 
Country X  P  66000000  0.1346  0.1346  0.2075  10  15  10 
Country X  G  65000000  0.1326  0.2672  0.2044  10  16  10 
Country X  M  54000000  0.1101  0.3773  0.1698  8  9  8 
Country X  Q  46000000  0.0938  0.4711  0.1447  7  17  7 
Country X  O  46000000  0.0938  0.5649  0.1447  7  12  7 
Country X  D  41000000  0.0836  0.6485  0.1289  6  9  6 
Country X  K  39000000  0.0795  0.7280  -  -  -  - 
Country X  C  27000000  0.0551  0.7831  -  -  -  - 
Country X  E  24000000  0.0489  0.8320  -  -  -  - 
Country X  A  22000000  0.0449  0.8769  -  -  -  - 
Country X  F  19000000  0.0387  0.9156  -  -  -  - 
Country X  L  16000000  0.0326  0.9482  -  -  -  - 
Country X  J  13000000  0.0265  0.9747  -  -  -  - 
Country X  H  12000000  0.0245  0.9992  -  -  -  - 
Country X  B  259000  0.0005  0.9997  -  -  -  - 
Country X  R  30000  0.0001  0.9998  -  -  -  - 
Country X  N  28000  0.0001  0.9999  -  -  -  - 
Country X  I  25000  0.0001  1  -  -  -  - 
Total  18  490342000  1  -  1  48  78  48 
(a):   The calculation is based on the conventions that the Total number of samples/isolates to be sampled in a year equals 170 and the 
Number of samples/isolates to be sampled per quarter equals 43, without accounting for any bacteria prevalence nor considering 
potential missingness (missing data). 
(b):   Colour legend: 
  Green Cells: Selected Stratum representing 60 % of the total throughput, inhabitants or isolates collected in the Member State. 
  Yellow Cells: Stratum for which the available samples/isolates is smaller than the number of samples/isolates that should be sampled. 
  Orange Cells: Stratum for which the available samples/isolates is larger than the number of samples/isolates that should be sampled. 
(c):   Final adjustments accounting for the prevalence of the bacteria and rate of recovery after storage are not addressed in this illustration. Technical specifications on randomised sampling for AMR monitoring 
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3.2.2.2.  Scenario II 
Under  Scenario  II,  it  is  considered  that the  number  of  isolates/samples  available/collected  in the 
quarter in some (at least one) each of the selected strata ( K . Epi . N Y ) is lower than the allocated number 
of isolates/samples to be sampled ( K . Epi . N X ), but the total number of available isolates/samples for the 
selected strata is equal to the required number of isolates/samples to be sampled, thus all available 
isolates/samples are taken. 
Table 3:   Numerical illustration of proportional allocation under Scenario II
(a),(b),(c). 
MS  Strata  Stratum 
capacity  Proportion  Cumulative 
proportion 
Allocation 
proportion 
(
K . Epi . N ) 
Samples per 
quarter 
(
K . Epi . N X ) 
Sample unit 
available 
(
K . Epi . N Y ) 
Samples 
taken
(c)
 
Country X  P  66000000  0.1346  0.1346  0.2075  10  12  12 
Country X  G  65000000  0.1326  0.2672  0.2044  10  8  8 
Country X  M  54000000  0.1101  0.3773  0.1698  8  7  7 
Country X  Q  46000000  0.0938  0.4711  0.1447  7  9  9 
Country X  O  46000000  0.0938  0.5649  0.1447  7  7  7 
Country X  D  41000000  0.0836  0.6485  0.1289  6  5  5 
Country X  K  39000000  0.0795  0.7280         
Country X  C  27000000  0.0551  0.7831         
Country X  E  24000000  0.0489  0.8320         
Country X  A  22000000  0.0449  0.8769         
Country X  F  19000000  0.0387  0.9156         
Country X  L  16000000  0.0326  0.9482         
Country X  J  13000000  0.0265  0.9747         
Country X  H  12000000  0.0245  0.9992         
Country X  B  259000  0.0005  0.9997         
Country X  R  30000  0.0001  0.9998         
Country X  N  28000  0.0001  0.9999         
Country X  I  25000  0.0001  1         
Total:  18  490342000  1 
 
1  48  48  48 
(a):  The calculation is based on the conventions that the Total number of samples/isolates to be sampled in a year equals 170 and the 
Number of samples/isolates to be sampled per quarter equals 43, without accounting for any bacteria prevalence nor considering 
potential missingness (missing data). 
(b):   Colour legend: 
  Green Cells: Selected Stratum representing 60 % of the total throughput, inhabitants or isolates collected in the Member State. 
  Yellow Cells: Stratum for which the available samples/isolates is smaller than the number of samples/isolates that should be sampled. 
  Orange Cells: Stratum for which the available samples/isolates is larger than the number of samples/isolates that should be sampled. 
(c):   Final adjustments accounting for the prevalence of the bacteria and rate of recovery after storage are not addressed in this illustration. 
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3.2.2.3.  Scenario III 
Under Scenario III, the number of isolates/samples available/collected in the quarter in some (at least 
one) of the selected strata ( K . Epi . N Y ) is not larger than the allocated number of isolates/samples to be 
sampled ( K . Epi . N X ), but the total number of available isolates/samples is larger than the required 
number of isolates/samples to be sampled. Next, from those strata ( ' K ) where ( ' K . Epi . N ' K . Epi . N Y X ³ ³ ³ ³ ) 
all  ' K . Epi . N Y will  be  taken,  and  the  rest  of  the  samples  to  be  collected 
( ∑ ∑ ∑ ∑ ∑ ∑ ∑ ∑
Î Î Î Î Î Î Î Î
- - - - = = = =
' K h
h . Epi . N
K j
j . Epi . N Y X sr ) will be redistributed among the remainder of the strata (
o
K ). The 
distribution among the remainder strata will be the minimum value between the samples available 
( o K . Epi . N Y ) and the  srmultiplied by the allocation proportion for each EpiU not yet sampled (
o
K ) 
divided  by  the  sum  of  all  allocation  proportions  of  the  units  not  yet  sampled,  the  mathematical 
expression would be: 
o
o
K
K h
h . Epi . N
h . Epi . N
h . Epi . N h , * sr , Y imum min Î Î Î Î " " " "
   
   
   
   
   
   
   
   
   
   
∑ ∑ ∑ ∑
Î Î Î Î
p
p
 
Table 4:   Numerical illustration of proportional allocation under Scenario III
(a),(b),(c). 
MS  Strata  Capacity  Capacity 
(%) 
Cumulative 
proportion 
Allocation 
proportion 
(
K . Epi . N p ) 
Samples per 
quarter 
(
K . Epi . N X ) 
Sample unit 
available 
(
K . Epi . N Y ) 
Samples 
taken
(c)
 
Country X  P  66000000  0.1346  0.1346  0.2075  10  15  15 
Country X  G  65000000  0.1326  0.2672  0.2044  10  6  6 
Country X  M  54000000  0.1101  0.3773  0.1698  8  7  7 
Country X  Q  46000000  0.0938  0.4711  0.1447  7  17  12 
Country X  O  46000000  0.0938  0.5649  0.1447  7  3  3 
Country X  D  41000000  0.0836  0.6485  0.1289  6  5  5 
Country X  K  39000000  0.0795  0.7280         
Country X  C  27000000  0.0551  0.7831         
Country X  E  24000000  0.0489  0.8320         
Country X  A  22000000  0.0449  0.8769         
Country X  F  19000000  0.0387  0.9156         
Country X  L  16000000  0.0326  0.9482         
Country X  J  13000000  0.0265  0.9747         
Country X  H  12000000  0.0245  0.9992         
Country X  B  259000  0.0005  0.9997         
Country X  R  30000  0.0001  0.9998         
Country X  N  28000  0.0001  0.9999         
Country X  I  25000  0.0001  1         
Total  18  490342000  1    1  48  53  48 
(a): The calculation is based on the conventions that the Total number of samples/isolates to be sampled in a year equals 170 and the 
Number of samples/isolates to be sampled per quarter equals 43, without accounting for any bacteria prevalence nor considering 
potential missingness (missing data). 
(b):   Colour legend: 
  Green Cells: Selected Stratum representing 60 % of the total throughput, inhabitants or isolates collected in the Member State. 
  Yellow Cells: Stratum for which the available samples/isolates is smaller than the number of samples/isolates that should be sampled. 
  Orange Cells: Stratum for which the available samples/isolates is larger than the number of samples/isolates that should be sampled. 
(c):   Final  adjustments  accounting  for  the  prevalence  of  the  bacteria  and  rate  of  recoverage  after  storage  are  not  addressed  in  this 
illustration.                                                                                                                                    Technical specifications on randomised sampling for AMR monitoring 
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3.2.2.4.  Scenario IV 
Under Scenario IV, it is considered that the number of isolates/samples available/collected quarterly 
in some (at least one) each of the selected strata ( K . Epi . N Y ) is lower than the allocated number of 
isolates/samples to be sampled ( K . Epi . N X ), and the total number of available isolates/samples is lower 
than the required number of isolates/samples to be sampled, thus all available isolates/samples from 
the selected strata are selected and the number of isolates/samples that need to be still sampled should 
come from the remainder of the strata (the 40 % initially excluded), considering the original ranking 
of strata performed on the basis of the capacity of  stratum (i.e. throughput, inhabitants or isolates 
collected). 
Table 5:   Numerical illustration of proportional allocation under Scenario IV
(a),(b),(c). 
MS  Strata  Stratum 
capacity  Proportion  Cumulative 
proportion 
Allocation 
proportion 
(
K . Epi . N ) 
Samples per 
quarter 
(
K . Epi . N X ) 
Sample unit 
available 
(
K . Epi . N Y ) 
Samples 
taken
(c)
 
Country X  P  66000000  0.1346  0.1346  0.2075  10  13  13 
Country X  G  65000000  0.1326  0.2672  0.2044  10  6  6 
Country X  M  54000000  0.1101  0.3773  0.1698  8  7  7 
Country X  Q  46000000  0.0938  0.4711  0.1447  7  11  11 
Country X  O  46000000  0.0938  0.5649  0.1447  7  3  3 
Country X  D  41000000  0.0836  0.6485  0.1289  6  5  5 
Country X  K  39000000  0.0795  0.7280      2  2 
Country X  C  27000000  0.0551  0.7831      6  1 
Country X  E  24000000  0.0489  0.8320      3  0 
Country X  A  22000000  0.0449  0.8769      4  0 
Country X  F  19000000  0.0387  0.9156      2  0 
Country X  L  16000000  0.0326  0.9482      9  0 
Country X  J  13000000  0.0265  0.9747      5  0 
Country X  H  12000000  0.0245  0.9992      2  0 
Country X  B  259000  0.0005  0.9997      3  0 
Country X  R  30000  0.0001  0.9998      4  0 
Country X  N  28000  0.0001  0.9999      8  0 
Country X  I  25000  0.0001  1      7  0 
Total  18  490342000  1  -  1  48  45  48 
(a):   The calculation is based on the conventions that the Total number of samples/isolates to be sampled in a year equals 170 and the 
Number of samples/isolates to be sampled per quarter equals 43, without accounting for any bacteria prevalence nor considering 
potential missingness (missing data). 
(b):   Colour legend: 
  Green Cells: Selected Stratum representing 60 % of the total throughput, inhabitants or isolates collected in the Member State. 
  Yellow Cells: Stratum for which the available samples/isolates is smaller than the number of samples/isolates that should be sampled. 
  Orange Cells: Stratum for which the available samples/isolates is larger than the number of samples/isolates that should be sampled. 
(c):   Final adjustments accounting for the prevalence of the bacteria and rate of recovery after storage are not addressed in this illustration. 
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3.2.2.5.  Scenario V 
Under  Scenario V,  it  is  considered  that  the  number  of  isolates/samples  available/collected  in  the 
quarter  in  some  of  the  selected  strata  ( K . Epi . N Y )  is  lower  than  the  allocated  total  number  of 
isolates/samples to be sampled ( K . Epi . N X ) and the rest of the strata cannot be sampled (for economical 
or practical reasons), or the number of samples in the remainder of the strata (the 40 % initially 
excluded) is less than the number of isolates/samples that still need to be sampled, then the next 
quarter(s) the number of samples to be taken should compensate for the number of samples that were 
not collected during the previous quarter(s). 
Take all isolates/samples from the selected strata ( 45 Nq = = = = ) and the number of isolates/samples to 
be taken in the next quarter will be equal to the original amount plus the number of samples/isolates 
that were not taken in the previous quarter e.g. in Table 5 two possible solutions would be:  
1. To compensate for the number of isolates/samples that were not collected the previous quarter 
directly in the next quarter, for instance the number of isolates/samples to be collected in the next 
quarter would be  ( ( ( ( ) ) ) ) ( ( ( ( ) ) ) ) 51 45 48 48 N 48 48 q = = = = - - - - + + + + = = = = - - - - + + + + . 
2. The number of samples/isolates to be collected in the following quarters (let  quarter n , represent the 
number  of  quarter  still  to  be  sampled,  assuming  that  3 nquarter = = = = )  would  be  adjusted  as 
( ( ( ( ) ) ) ) ( ( ( ( ) ) ) ) ( ( ( ( ) ) ) )
49
3
45 48
48
n
N 48
48
n
N 48 n * 48
quarter
q
quarter
q quarter = = = =
- - - -
+ + + + = = = =
- - - -
+ + + + = = = =
- - - - + + + +
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Table 6:   Numerical illustration of proportional allocation under Scenario V
(a), (b),(c). 
MS  Strata  Stratum 
capacity  Proportion  Cumulative 
proportion 
Allocation 
proportion 
(
K . Epi . N ) 
Samples per 
quarter 
(
K . Epi . N X ) 
Sample unit 
available 
(
K . Epi . N Y ) 
Samples 
taken
(c)
 
Country X  P  66000000  0.1346  0.1346  0.2075  10  13  13 
Country X  G  65000000  0.1326  0.2672  0.2044  10  6  6 
Country X  M  54000000  0.1101  0.3773  0.1698  8  7  7 
Country X  Q  46000000  0.0938  0.4711  0.1447  7  11  11 
Country X  O  46000000  0.0938  0.5649  0.1447  7  3  3 
Country X  D  41000000  0.0836  0.6485  0.1289  6  5  5 
Country X  K  39000000  0.0795  0.7280      0  0 
Country X  C  27000000  0.0551  0.7831      0  0 
Country X  E  24000000  0.0489  0.8320      0  0 
Country X  A  22000000  0.0449  0.8769      0  0 
Country X  F  19000000  0.0387  0.9156      0  0 
Country X  L  16000000  0.0326  0.9482      0  0 
Country X  J  13000000  0.0265  0.9747      0  0 
Country X  H  12000000  0.0245  0.9992      0  0 
Country X  B  259000  0.0005  0.9997      0  0 
Country X  R  30000  0.0001  0.9998      0  0 
Country X  N  28000  0.0001  0.9999      0  0 
Country X  I  25000  0.0001  1      0  0 
Total  18  490342000  1    1  48  45  45 
(a):   The calculation is based on the conventions that the Total number of samples/isolates to be sampled in a year equals 170 and the 
Number of samples/isolates to be sampled per quarter equals 43, without accounting for any bacteria prevalence nor considering 
potential missingness (missing data). 
(b):   Colour legend: 
  Green Cells: Selected Stratum representing 60 % of the total throughput, inhabitants or isolates collected in the Member State. 
  Yellow Cells: Stratum for which the available samples/isolates is smaller than the number of samples/isolates that should be sampled. 
  Orange Cells: Stratum for which the available samples/isolates is larger than the number of samples/isolates that should be sampled. 
(c):   Final adjustments accounting for the prevalence of the bacteria and rate of recovery after storage are not addressed in this illustration. 
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3.2.3.  Accounting for the prevalence and recovery rate of the bacteria 
The number of samples to be collected from each animal population in order to achieve the number of 
isolates  required depends on  the  prevalence  of  the  bacteria  considered  (C. jejuni,  C. coli,  E. coli, 
E. faecium and E. faecalis). The CA should estimate the number of samples to be collected in order to 
obtain the required number of bacterial isolates, given the prevalence of those particular bacteria in 
caecal samples of the specific animal populations (e.g. C. jejuni in broilers and fattening turkeys, and 
C. coli in broilers and fattening pigs). Assuming that the sample is selected randomly and that the 
prevalence  in  the  animals  slaughtered  in  the  selected  slaughterhouses  is  similar  to  the  national 
prevalence, the number of samples to be collected can be calculated as the inverse of the prevalence. 
For example, if the prevalence was 70 %, the number of samples to be collected in order to ensure the 
collection of 170 isolates would be equal to 242 (170/0.7 = 242). 
Regarding Campylobacter, in those MS where a particularly marked seasonality in the prevalence 
occurs, it may be desirable, for cost-effectiveness reasons, to focus on the quarters {seasons} where 
the prevalence is not low to very low and the chance of isolating Campylobacter higher. 
For indicator E. coli, which is highly prevalent, the number of samples to be collected would be 
slightly higher than the number of isolates required, as it can be assumed that these bacteria are almost 
constantly recovered from animal caecal samples (prevalence rates/isolation rates ranging between 
95 % and 100 %).  
For indicator Enterococcus spp., the monitoring of AMR may be performed on a voluntary basis. The 
expected  prevalence  of  enterococci  is  typically  much  lower,  for  example  around  50 %  in  caecal 
samples from broilers, and this should be accounted for. The number of samples could be reduced, if 
one isolate of each of the species E. faecium and E. faecalis, from the same sample, is taken. For this 
purpose, the samples collected could be tested for the Presence of Enterococcus spp. and more than 
one  isolated  strain  of  Enterococcus  spp.  per  sample  (typically  between  1  and  5)  stored  to  be 
subsquently speciated by PCR. Among the E. faecalis and E. faecium isolates available, only one per 
species and per sample should be finally tested for susceptibility and the results for E. faecium and 
E. faecalis  reported  separately.  Low  numbers  of  E. faecium  and  E. faecalis  isolates  per  animal 
population would mean that for these animal populations there is a decreased precision of the estimate 
of the proportion of resistance and it would be more difficult to detect trends over time. 
As previously indicated, in order to also take into account a 5 % missingness (missing data), the 
number  of  yearly  samples  to  be  collected  should  be  further  inflated  by  5 %,  e.g.  179  samples 
(170*1.05 = 178.5)  or  254 samples  (242*1.05 = 254)  in  the  examples  given  above.  As  the  strain 
recovery rate after storage may be less than 100 %, the number of yearly samples to be collected 
should be further inflated to offset this, based on the experience of the laboratories, for example by an 
additional 2 %. 
3.2.4.  Simple random sampling of samples/isolates within the stratum 
Simple random sampling (SRS) is the simplest form of drawing elements from a targeted population. 
It involves drawing elements successively such that each population member has equal and a non-zero 
probability of being selected.  
A SRS procedure is applied in order to select an adequate number of isolates/samples to be taken by 
quarter. If, in practice, it is more convenient for the central and local CAs, the SRS may also be 
planned and performed by month. For certain sampling plans, it may be necessary to perform a series 
of SRS processes, for example, regarding the sampling of caecal samples at slaughter, working days 
should be selected first, then batch(es)/lot(s) of carcases originating from the same epidemiological 
unit (flock or herd) on the selected days, and finally one carcase (or a number of carcases in the case 
of a grouped sample) from the selected batch(es).  Technical specifications on randomised sampling for AMR monitoring 
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Considering  a  list  with  N  elements  (e.g.  isolates  in  isolate  collection  or  days/working  days  in  a 
month), a sample of n elements should be drawn. Each list element is assigned a number, say, 1,…N, 
and the selection can proceed the following way: (i) randomly select a number between 1 and N (this 
can  be  done  with  excel  using  the  = RANDBETWEEN(1,  N)  function  and  many  other  statistical 
software). The element corresponding to the selected number is included in the sample and it cannot 
be selected again, this is referred to as sampling without replacement.  
4.  Sampling plans of Salmonella isolates from primary production of poultry 
4.1.  Objective 
The  objective  is  to  collect  and  test  for  antimicrobial  susceptibility  at  least  170  representative 
Salmonella  spp.  isolates  obtained  respectively  from  the  populations  of  laying  hen  flocks,  broiler 
flocks and fattening turkey flocks in the MS on a yearly basis (whether the sampling was performed 
by the CA or under its supervision, by the FBO). In any case, operators should carefully check that the 
Salmonella strains randomly selected and submitted for susceptibility testing originate from different 
(positive) flocks and, optimally, from different farms. 
4.2.  The delineation of animal populations 
Flocks of broilers, laying hens and fattening turkeys (in the MS where more than 10 000 tonnes are 
slaughtered on a yearly basis) in production between 1 January to 31 December and covered by the 
Salmonella National Control Programme (NCP) are eligible for AMR Monitoring in Salmonella spp. 
isolates. 
4.3.  Samples and the sampling designs 
Two approaches are advisable, according to the Salmonella prevalence in the populations of laying 
hen flocks, broiler flocks, fattening turkey flocks and the availability of a central database recording 
the positive flocks in real time.  
4.3.1.  Approach 1: proportionate stratified sampling of isolates 
This approach follows a stratified sampling strategy with proportional allocation within a sampling 
frame  of  Salmonella  spp. strains  deriving  from  the  isolate  collections  available  from  the  official 
laboratories  and/or  other  laboratories  designated  by  the  CA  to  carry  out  testing  under  the  NCP 
requirements
14  involved in the  Salmonella  NCP.  For  this  purpose,  the  following  parameters  are 
considered when adapting the generic stratified sampling approach to this specific sampling: 
  Strata: the laboratories involved in the Salmonella NCP
15  
  Stratum capacity: the size of the collection of Salmonella strains originating from the animal 
population  examined  and  isolated  within  the  framework  of  the  NCP  in  the  previous  year, 
available in the laboratory. 
  Epidemiological  unit  (EpiU):  For  the  purpose  of  this  sampling,  epidemiological  units  are 
represented by flocks of broilers/laying hens/fattening turkeys. 
The Salmonella spp. strains respectively isolated from broiler flocks, laying hen flocks and fattening 
turkey  flocks,  covered  by  the  Salmonella  NCP  of  the  MS  and  in  production  from  1 January  to 
31 December are eligible. It is of note that S. Gallinarum Pullorum strains as well as the Salmonella 
strains isolated within the context of clinical investigations are excluded for the purpose of the AMR 
                                                       
14   Designated under Reg. 2160/2003 article 12(1)(a). 
15   As a logistic compromise, it may be acceptable that the sampling plan focus on those laboratories accounting for 80 % of 
the total number of Salmonella isolates in the poultry production in question within the MS in the previous year. If the 
Salmonella prevalence in the poultry productions is important and the laboratories involved in the NCPs numerous, it may 
be envisaged to account for organisational constraints to further limit the strata (laboratories) involved in the sampling 
plans, provided that a good geographical representation is assured and any particular subpopulations are not systematically 
included/excluded. Technical specifications on randomised sampling for AMR monitoring 
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monitoring. Each MS shall list all official laboratories and/or other laboratories designated by the CA 
involved in the testing of samples within the framework of the NCP and rank them by decreasing 
order by number of eligible Salmonella spp. strains isolated from laying hen/broiler/fattening turkey 
flocks between 1 January to 31 December in the previous year. A sampling plan is designed by the 
CA at the beginning of the year in order to plan the activity and adapted as necessary in the course of 
the  year  so  that  the  required  number  of  representative  bacterial  isolates  can  be  collected  and 
eventually submitted for susceptibility testing. 
The list of participating laboratories accounting for (at least 80 % of) the total number of Salmonella 
isolates is then compiled starting with the laboratories with largest isolate collection (to be considered 
separately  per  animal  population  of  origin).  The  isolate  sample  size  for  each  laboratory  in  the 
sampling period is allocated proportionally to the laboratory isolate collection size of the previous 
year. Every quarter, simple random sampling is performed within the sampling frame of strains (see 
approach presented in Section 3.2.4.), unique per positive flock, up to the selection of the quarter of 
yearly isolate sample size. Either the sampling frame of Salmonella strains in the collections of the 
laboratories may include only strains unique per positive flock or a check for duplicates per positive 
flock is carried out after the random selection. 
In the particular case where the number of available isolates is lower than the quarter of the yearly 
isolate sample size, the scenario III, IV and V should apply in order to complement the isolate sample 
size up to (at least) 170 isolates.  
In  the  case  where less  than  170  Salmonella  isolates  have  been isolated in  each  of  these  poultry 
populations in a given year, all available isolates should be included in AMR monitoring, provided 
that there is no more than one isolate per Salmonella serovar from the same flock (epidemiological 
unit) per year. 
4.3.2.  Approach 2: simple random sampling of positive flocks 
An alternative approach is to perform a simple random sampling (SRS) within the sampling frame of 
flocks involved in the NCP and which have tested positive for Salmonella. In the MS where a national 
database records the flocks of laying hens/broilers/fattening turkeys tested positive for Salmonella 
spp. (all serovars) in real time, it is advisable to devise the sampling design as a quarterly SRS of the 
flocks tested positive for Salmonella. Every quarter, the number of positive flocks to be randomly 
selected among the flocks tested positive over the quarter equals 43 flocks. The SRS is performed 
according to the procedure developed in Section 3.2.4. 
A unique strain of Salmonella spp. (in the case all the isolates recovered belong to the same serovar) 
or  a  unique  strain  per  Salmonella  serovar  (in  the  case  the  isolate  recovered  belong  to  different 
serovars) recovered from each positive flock randomly selected is submitted for susceptibility testing. 
If more than one strain has been isolated from the flock, a random selection of a strain among those 
isolated is performed from the competent laboratory collection and included in the AMR monitoring 
programme. 
If  less  than  43  flocks  tested  positive  in  a  given  quarter,  the  total  number  of  strains  available  is 
included in the AMR monitoring programme. In this case, it is advisable that the next quarter(s) the 
number of isolates to be taken should compensate for the number of samples that were not collected 
during the previous quarter(s), if possible. Technical specifications on randomised sampling for AMR monitoring 
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5.  Sampling plans of representative caecal isolates at slaughter 
5.1.  Objective 
The objective is to collect and test for antimicrobial susceptibility representative caecal isolates of: 
  E. coli from broilers, fattening turkeys, fattening pigs and bovines under 1 year of age; 
  C. jejuni from broilers and fattening turkeys; 
  Extended Spectrum Beta-Lactamase (ESBL)-/AmpC-/carbapenemase-producing E. coli from 
broilers, fattening turkeys, fattening pigs and bovines under 1 year of age; 
and on a voluntary basis: 
  E. faecium and E. faecalis from broilers, fattening turkeys, fattening pigs and bovines under 
1 year of age; 
  C. coli from broilers and fattening pigs. 
MS  assess  which  specific  combinations  of  animal  populations  and  bacteria  should  be  sampled 
according to Decision 2013/652/EU, what number of isolates/samples should be collected and tested, 
and in which years. Table 7 can be used as a means to identify the isolates/samples to be collected. 
5.2.  The delineation of the animal populations 
The eligible populations of broilers/fattening turkeys/fattening pigs/bovines of less than 1 year of age 
cover those domestically produced and slaughtered in the slaughterhouses covering at least 60 % of 
the all broilers/fattening turkeys/fattening pigs/bovines of less than 1 year of age slaughtered in the 
MS. 
It is proposed that domestically produced broilers, fattening turkeys, fattening pigs and calves of less 
than one year of age may be respectively defined: 
  Regarding broilers and fattening turkeys, as birds hatched and raised in the MS as well as 
those imported/traded as day-old chicks in the MS (i.e. hatched abroad).  
  Regarding fattening pigs and calves of less than one year of age, as those animals produced 
and slaughtered in the MS and excluding those imported and intended for direct slaughter 
after importation. Therefore, pigs imported/traded in the MS as post-weaners, growers and 
fatteners  are  considered  as  domestically  produced  animals.  As  a  general  guideline, 
domestically produced animals should spend at least about 50 % of their lifespan in the MS. 
 Technical specifications on randomised sampling for AMR monitoring 
 
EFSA Journal 2014;12(5):3686  24 
 
Table 7:   Animal populations to be sampled for caecal samples at slaughter and number of samples/isolates foreseen per bacteria and per year, to be 
sampled on a mandatory or on a voluntary basis under Decision 2160/2013. 
Animal population  Bacteria  2014  2015  2016  2017  2018  2019  2020 
Broilers  C. jejuni  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c) 
  C. coli
(b)  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c) 
  E. coli  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c) 
  E. faecalis, E. faecium
(b)  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c) 
  enzyme-producing E. coli
(e)  300 samples
(b,d)  -  300 samples
(d)  -  300 samples
(d)  -  300 samples
(d) 
Fattening turkeys
(a)  C. jejuni  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c) 
  E. coli  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c) 
  E. faecalis, E. faecium
(b)  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c) 
  enzyme-producing E. coli  300 samples
(b,d)  -  300 samples
(d)  -  300 samples
(d)  -  300 samples
(d) 
Fattening pigs  C. coli
(b)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  - 
  E. coli  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  - 
  E. faecalis, E. faecium
(b)  -  170 isolates
(c)  -  170 isolates
(c)  -  170 isolates
(c)  - 
  enzyme-producing E. coli  -  300 samples
(d)  -  300 samples
(d)  -  300 samples
(d)  - 
Bovines < 1 year of age
(a)  E. coli  -  170 isolates  -  170 isolates  -  170 isolates  - 
  E. faecalis, E. faecium
(b)  -  170 isolates  -  170 isolates  -  170 isolates  - 
  enzyme-producing E. coli  -  300 samples
(d)  -  300 samples
(d)  -  300 samples
(d)  - 
(a):   to be sampled only if production (turkey meat, meat of bovines under 1 year of age) is more than 10 000 t per year. 
(b):   to be sampled on a voluntary basis. 
(c) :   85 isolates if production (poultry meat, pig meat) is less than 100 000 t per year. 
(d) :   150 samples if production (poultry meat, pig meat) is less than 100 000 t per year or if production (bovine meat) is less than 50 000 t per year. 
(e) :   enzyme-producing E. coli states for ESBL-/AmpC-/carbapenemase-producing E. coli 
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5.3.  Samples and sampling design 
A sampling plan is to be designed by the CA at the beginning of the year in order to ensure that the 
required  number  of  representative  bacterial  isolates  is  collected  and  eventually  submitted  for 
susceptibility testing. For this purpose, the following parameters are considered when adapting the 
generic stratified sampling approach to this specific sampling: 
  Strata (1
st stage): the slaughterhouses where eligible animals are slaughtered within the MS. 
  Stratum capacity: the annual throughput of domestically produced meat of the slaughterhouse 
during the previous year
16. 
  Strata  (2
nd  stage):  For  the  purpose  of  this  sampling  at  slaughter,  batches/lots  of  carcases 
originating from the same epidemiological unit (flock of broilers/fattening turkeys and holding of 
fattening pigs/bovines under 1 year of age) are used for a second stage selection. As indicated 
below, no more than one caecal content sample (single or pooled)
17 per batch/lot of carcases of 
the same should be collected. 
Accounting for the bacteria prevalence, possible missingness and possible loss during storage, for the 
definition of the number of samples to be collected in each quarter of the year from each selected 
slaughterhouse should ensure that the isolates required by Decision 2013/652/EU are collected. If after 
the first quarter the CA realises that the number of samples is not sufficient to obtain the expected 
number of isolates, the number of samples to be collected in the following quarter(s) may be  adapted 
and recalculated (see Scenario V). 
5.3.1.  Proportional allocation 
Each  MS  will  rank  all  slaughterhouses  by  throughput  of  eligible  animals  between  1  January  to 
31 December in the previous year. Starting with the slaughterhouses of largest throughput, sufficient 
slaughterhouses  should  be  enrolled  to  cover  at  least  60 %  of  the  national  throughput  of  animals 
domestically produced. A list of participating slaughterhouses is then compiled, and the predetermined 
number  of  carcases  to  be  sampled  is  distributed  according  to  the  proportional  throughput  from 
1 January to 31 December in the previous year.  
5.3.2.  Simple random sampling of days, batch(es) of carcases and carcases 
For each month, sampling sessions should be allocated randomly to the days of the month, based on 
operating days for that particular slaughterhouse. Simple random sampling techniques, as previously 
described, should be used. Preferably, a maximum of one caecal sample per slaughterhouse is sampled 
per day to ensure that there is no correlation between positive results that may derive from direct or 
indirect contact between sampled animals before slaughter. For this purpose, a number of sampling 
days (equal to the sample size) is randomly selected from the operating days of the slaughterhouse. 
For each slaughterhouse each month, a number between 1 and 31 shall be selected at random. If the 
randomly selected number is a slaughtering day, for that month, then that day is selected for sampling. 
If not, then a new number is selected randomly. This process is preferentially performed once a month 
and repeated so many times as there are samples to be collected at the slaughterhouse. In addition, a 
number  of  practical  issues  may  need  to  be  taken  into  account  when  defining  sampling  days  and 
samples to be taken at slaughterhouse. Sampling days may need to be restricted based on laboratory 
and  courier limitations, e.g.  in  some  situations  it  may  be  necessary to exclude  Fridays.  For each 
sampling day, if more batches are slaughtered and more than one sample a day is collected, batches to 
be sampled should be selected randomly. From each selected batch/lot of carcases originating from the 
                                                       
16   In  the  case  statistics  on  the  annual  throughput  of  domestically  produced  meat  of  slaughterhouses are  not  available, 
statistics on the annual throughput of meat (whatever is the origin of the animals slaughtered) are used. 
17   A single caecal sample derives from the caecal content of both caecal diverticula from one carcase, while a pooled caecal 
sample derives from the caecal content of a number of carcases (e.g. five carcases). In the case of low  Campylobacter 
prevalence, pooled caecal samples may be envisaged. Technical specifications on randomised sampling for AMR monitoring
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same epidemiological unit, one caecal content sample (single or pooled) from healthy
18 animal(s) 
should  be  randomly  selected  and  collected.  This  would  ensure  that  only  one  isolate  per 
epidemiological unit of origin per year is finally submitted to susceptibility testing. Where it is not 
possible to sample only one caecal sample per day per slaughterhouse due to logistical reasons, it may 
be proposed that up to five caecal samples per day can be sampled
19.  
A stratification by slaughterhouse does not rule out the possibility of taking account of production 
types (e.g. for broilers: organic, free-range, standard), notably where relevant statistics/information are 
available. 
6.  Sampling plans of representative Salmonella isolates from carcases at slaughter 
6.1.  Objective 
The objective is to collate and test for antimicrobial susceptibility at least 170 representative isolates 
of Salmonella spp. obtained respectively from carcasses of broilers, fattening turkeys, fattening pigs 
and bovines under 1 year of age
20. For the purpose, a retrospective sampling strategy should be applied 
within the collection(s) of Salmonella spp. isolates obtained from official samples collected by the CA 
to verify compliance of the FBO with the process hygiene criteria established by points 2.1.3, 2.1.4 
and 2.1.5 of Chapter 2 of Annex I of Regulation (EC) No 2073/2005. 
In the case where the isolates obtained from official samples collected by the CA are not sufficient to 
reach the requested number of isolates to be tested for susceptibility, representative Salmonella spp. 
isolates recovered by FBO in accordance with the procedures established by points 2.1.3, 2.1.4 and 
2.1.5 of Chapter 2 of Annex I of Regulation (EC) No 2073/2005, may be used to complement those 
collected by the CA and included in the AMR monitoring programme. FBO should provide them upon 
a specific request of the CA. Should the isolates transmitted not be fully serotyped, the CA should 
foresee a serotyping step before testing them for antimicrobial sensitivity. 
6.2.  The delineation of the populations 
The MS should first assess from which food-producing animal populations Salmonella spp. isolates 
should be collated, what number of isolates should be collected and tested and in which year, and this 
should be performed in accordance with the provisions of Decision 2013/652/EU (Cf. Table 8).  
Table 8:   Number of Salmonella spp. isolates obtained from carcases requiring susceptibility testing 
per animal populations and per year. 
Carcases  Bacteria  2014  2015  2016  2017  2018  2019  2020 
Broilers  Salmonella 
170 
isolates
(b) 
- 
170 
isolates
(b) 
- 
170 
isolates
(b) 
- 
170 
isolates
(b) 
Fattening 
turkeys  Salmonella 
170 
isolates
(b) 
- 
170 
isolates
(b) 
- 
170 
isolates
(b) 
- 
170 
isolates
(b) 
Fattening 
pigs  Salmonella  - 
170 
isolates
(b) 
- 
170 
isolates
(b) 
- 
170 
isolates
(b) 
- 
Bovines <1 
year of age
(a) 
Salmonella  -  170 
isolates  -  170 
isolates  -  170 
isolates  - 
(a):  to be sampled only if production (meat of bovines under 1 year of age) is more than 10 000 tonnes per year. 
(b):  85 isolates if production (poultry meat, pig meat) is less than 100 000 tonnes per year. 
                                                       
18   Condemned or underweight carcases and animals undergoing emergency slaughter should be notably excluded. 
19   In exceptional cases, when it appears for particular economical and organisational reasons that it would be more cost-
effective, a greater number of samples in a day could be collected, e.g. more than five caecal samples may be sampled per 
day per slaughterhouse, provided that a potentially introduced clustering effect is accounted for by increasing the sample 
size of the monitoring. 
20   In MS where more than 10 000 tonnes are slaughtered per year. Technical specifications on randomised sampling for AMR monitoring 
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6.3.  The sample and the sampling design 
6.3.1.  Stratified sampling of Salmonella spp. isolate from carcases obtained by CA 
At first instance, collections of Salmonella isolates originating from official samples taken by the CA 
should  be  used  as  a  source  of the isolates to  be tested  quarterly.  For the  purpose,  the  following 
parameters are considered when adapting the generic stratified sampling approach to this  Specific 
sampling plan: 
  Strata: the (official) laboratories housing collections of Salmonella spp. isolates obtained from 
the carcases of  the food-producing animal  populations addressed, sampled for testing and 
verification of compliance of the Salmonella food hygiene criteria; 
  Stratum capacity: the size of the collection of Salmonella spp. isolates originating from the 
examined animal population during the study period, available in the laboratory; 
  Epidemiological unit (EpiU): batch of carcases originating from the same flock (broilers and 
fattening turkeys) or holding (fattening pigs and bovines under 1 year of age) of origin of the 
animals  sampled.  No  more  than  one  sample  per  epidemiological  unit  per  year  should  be 
collected. 
A similar approach to that presented in the framework of collecting Salmonella strains from isolate 
collections in the laboratories involved in the Salmonella NCP should apply here. 
6.3.2.  Complementary stratified sampling of Salmonella spp. isolate obtained by FBOs 
A  problem  that  may  arise,  especially  for  some  animal  populations  in  which  Salmonella  spp. 
prevalence in carcasses is low, is the lack of isolates available in the above collections in laboratories 
at the end of each quarter. As indicated above, Decision 2013/652/EU foresees the possibility that 
additional isolates, originating from samples taken by FBO, are used to complement the isolates to be 
submitted to susceptibility testing. It is suggested that this is considered at the end of each quarter of 
the year, if isolates from official sampling are not sufficient. The situation would be the one described 
in Scenario V above. Such a scenario would need to be adapted to this situation as follows: before 
recalculating  the  isolates  to  be  collected  in  the  following  quarter(s),  the  CA  should  consider  the 
possibility to reach the required number of isolates for that quarter by including isolates provided by 
FBO, if available among FBO’s collections of isolates. When doing so, the CA should, by preference, 
select isolates originating from slaughterhouses or slaughtered batches not already covered by isolates 
originating from official samples. This would ensure that only one isolate per epidemiological unit per 
year is finally submitted to susceptibility testing. If the number of required isolates cannot be reached 
also after complementing the isolates from official sampling with the ones from FBO, the number of 
isolates required in the following quarter(s) can be recalculated through the procedure described in 
Scenario V. 
7.  Sampling designs of representative isolates from meat at retail 
7.1.  Objective 
The objective is to collect 300 representative random samples of fresh meat of broilers, pig meat and 
bovine  meat,  respectively  and  to  test  them  for  the  presence  of  ESBL-/AmpC-/carbapenemase-
producing isolates of E. coli. However, in MS with a production of less than 100 000 tonnes of poultry 
meat slaughtered per year, less than 100 000 tonnes of pig meat slaughtered per year and less than 
50 000  tonnes  bovine  meat  slaughtered  per  year
21  the  MS  shall analyse 150 samples instead of 
300 samples for each corresponding specific combination. 
                                                       
21   According to the most recent data available at EUROSTAT (http://epp.eurostat.ec.europa.eu). Technical specifications on randomised sampling for AMR monitoring 
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7.2.  The delineation of the meat categories 
The eligible categories of fresh meat of broilers, pig meat and bovine meat cover those marketed at the 
retail stage in the NUTS-3 area representing at least 80 % of the population in the MS.  
Within the framework of this sampling plan, retail is understood as outlets selling directly to the final 
consumer for subsequent domestic consumption, i.e. outlets such as supermarkets, specialist shops, 
markets and excluding catering activities, restaurants, wholesalers and similar outlets. 
Within the framework of this sampling plan, fresh meat is understood as chilled meat (meaning that 
frozen meat is excluded), including meat that is wrapped, vacuum-wrapped or wrapped in a controlled 
atmosphere. As there is a specific interest as regards the consumer being exposed further up the food 
chain, then carcases or meat portions with skin on from broilers should be sampled as a measure of the 
likely heaviest degree of contamination from the animals. Selecting a standard type of meat that is 
readily available in all MS is important for harmonised monitoring. Un-skinned carcases/meat portions 
(diced or breast) for broilers and samples of meat of pigs, and meat of cattle (both displayed without 
skin, typically) (sliced or diced) should be sampled. 
7.2.1.  Sampling design 
A proportionate stratified sampling scheme is used at the MS level whereby the samples are allocated 
proportionally to the size of the human population in the regions (NUTS-3 area) accounting for at least 
80 %
18 of the national population. Next, at the second level, are the retail outlets to be sampled. At the 
third  level,  samples  within  the  different  meat  categories  to  be  sampled  are  selected.  The 
300/150 samples (of each meat category) are to be allocated in proportion to the size of the human 
population in the NUTS-3 area. The assumption underpinning the allocation of sample numbers to the 
regions, within MS, according to the size of their human populations, is that the human population 
sizes are fairly proportional to the volume sizes of the selected food categories on the market.  
For  the  purpose  of  the  proportional  allocation  of  sample  numbers,  the  following  parameters  are 
considered when adapting the generic stratified sampling approach to this specific sampling plan: 
  Strata: the NUTS-3 area accounting for at least 80 % of the national population
22; 
  Stratum capacity: the number of inhabitants according to the most recent data available; 
  Epidemiological  unit  (EpiU):  lot  of  chilled  fresh  meat.  No  more  than  one  sample  per 
epidemiological unit per year should be collected. 
Ideally, the central CA should draw up a sampling plan following the rules described below and based 
on the best marketing data available.  
Selection of the retail outlet categories to be targeted 
The CAs are responsible for choosing the retail outlets to be included. Typical types of retail outlets 
that could be included for sampling are: supermarkets and small shops/speciality delicatessens (e.g. 
traditional craft butcher’s businesses). Stratification on the major types of retail outlets allows for 
accounting for potential differences in supply chains (imported vs. domestic) and meat production 
types (e.g. for broiler meat: farmer’s, organic, free-range, standard etc.). The following rule shall be 
used to choose the types of retail outlets to be sampled and needs to be followed for each of meat 
categories: 
  If the biggest category of outlets (for example supermarkets) supply at least 80 % of the 
market of a meat category then samples only need to be taken from those outlets. Where that 
                                                       
22   A sampling frame representing at least 80 % of the target population is proposed as a logistic compromise, since the 
legislation does not foresee any restriction of the study population. However, in certain MS, it might be necessary to 
further limit the NUTS-3 areas involved in the sampling frame to the regions with high population density to account for 
logistical and organisational constraints, in particular in those geographically large MS with sparsely populated regions.  Technical specifications on randomised sampling for AMR monitoring 
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is not the case, the second largest outlet category should be added and so on until at least 80 % 
of the market is covered. 
  The number of samples that should be taken from each retail outlet category included in the 
sampling plan should be proportionate to the market share of that outlet category within the 
targeted outlet categories. 
If  no  major  differences  in  supply  chains  and  meat  production  types  are  expected  between  the 
categories of outlets, sampling may be limited to the biggest category of outlets in the MS to reduce 
logistical constraints.  
With respect to the definition of sampling days and selection of the samples to be taken within each 
epidemiological unit, simple random sampling techniques should be used. In addition, a number of 
practical issues may need to be taken into account when defining sampling days and samples to be 
taken at retail. For each month sampling sessions should be allocated randomly to the days of the 
month, based on working days. Sampling days may need to be restricted based on laboratory and 
courier limitations, e.g. in some situations it may be necessary to exclude Fridays. 
At the same visit to a retail outlet, up to five different meat batches/lot per meat category can be 
sampled  without  preselecting  samples  based  on  the  origin  of  the  food.  It  is  essential  that  cross 
contamination is avoided during the collection of fresh meat samples. Precautions must therefore be 
taken at all stages to ensure that the equipments used during sampling, transport and storage are not 
contaminated.  
7.3.  Complementary AMR monitoring in additional animal populations and food categories 
To complement AMR monitoring previously described, MS may be interested in monitoring AMR in 
other  animal  species/populations,  food  categories  and  points  of  the  food  chain  other  than  those 
foreseen by Decision 2013/652/EC. This may include may include monitoring of  imported (fresh or 
frozen) meat from third countries at the border inspection posts, non-domestically produced meat (e.g. 
animals slaughter in the country but born and raised abroad) or frozen meat at retail, and other animal 
species (e.g. rabbit, sheep). 
For imported meat, a stratified sampling design per MS with proportional allocations of the number of 
isolates to the quantities imported from third countries of origin, appears to be the best and the most 
cost-effective option.  For example, the monitoring of AMR in poultry meat imported from third-
countries may be a specific target of this kind of complementary monitoring regarding imported meat. 
The statistics on broiler meat importations issued by  EUROSTAT could be used to construct the 
sampling plan. In any case, AMR data deriving from the monitoring of imported meat from third 
countries should be reported separately.  
8.  Review of routine monitoring of AMR 
It is recommended that these technical specifications be re-assessed taking into account lessons learnt 
during  implementation.  This  may  be  necessary  because  the  results  will  add  new  experience  and 
knowledge  to an  emerging  and  evolving  area  of  AMR.  At the  time  of the  development  of  these 
technical specifications, some areas  were less explored, such as the monitoring of ESBL-/AmpC-
/Carbapenemase-producing bacteria. 
In a number of the sampling plans proposed above, sampling frames may not represent the full target 
population  (as  a  compromise  at  least  60 %  or  80 %  of  the  study  population),  provided  that  any 
particular subpopulations (e.g. those animals produced by particular operators or raised in particular 
regions)  are  systematically  excluded.  It  is,  therefore,  recommended  that  MS  assess  how  well  the 
sampling frame matches the target population and whether any sub-populations are less represented to 
help  understand  any  limitations  in  the  monitoring  programmes.  An  annual  assessment  of 
representativeness of each monitored population will enable EFSA and MS to better understand the Technical specifications on randomised sampling for AMR monitoring 
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outcomes  of  the  monitoring.  Changes  to  representativeness,  over  time  or  between  MS,  may  help 
explain changes in AMR patterns or differences between MS.  
A review and a regular update of these technical specifications would allow for the adjustment of 
sampling frames (stratifications), sample sizes and data collection procedures and would account for 
any  improvement  in  laboratory  methods  incorporated  into  the  programme  and  the  most  recent 
literature available. This would increase the quality of occurrence of resistance estimates in future 
monitoring.  
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GLOSSARY 
For the purpose of this document, the following definitions apply. 
Capacity: total number of elements on which a stratum consists. For the purpose of this document, 
capacity is represented by: i) the number of isolates available in the case of official laboratories; ii) the 
number of animals slaughtered in the case of slaughterhouses; iii) the size of the human population in 
the case of NUTS-3 regions. 
Competent authority: means the central authority of a Member State competent for the organisation 
of official controls or any other authority to which that competence has been conferred, it shall also 
include, where appropriate, the corresponding authority of a third country
23. 
Domestically produced animals: animals born and bred within the country of slaughter, and animals 
that spent part of their breeding life in the slaughter country, during which they may have been treated 
with antimicrobials. 
Epidemiological unit: for the purpose of this document, it represents the unit of a population from 
which representative samples at primary production and slaughterhouse level should be collected; in 
particular, these are represented by flocks (poultry) or holdings (pigs and bovines) (see slaughter 
batch). 
Fresh meat: meat that has not undergone any preserving process other than chilling, freezing or 
quick-freezing, including meat that is vacuum-wrapped or wrapped in a controlled atmosphere. In this 
document, within the framework of the sampling plan of fresh meat at retail, fresh meat only covers 
chilled meat, including meat that is wrapped, vacuum-wrapped or wrapped in a controlled atmosphere.  
Harmonised monitoring of antimicrobial resistance: monitoring aimed at providing comparable 
data on the occurrence of antimicrobial resistance in zoonotic and commensal bacteria. 
Isolate: microorganism obtained in pure culture from a sample. 
Isolation: ‘any procedure in which a given species of organism, present in a particular sample or 
environment, is obtained in pure culture’ (Singleton and Sainsbury, 1987). 
Monitoring: system of collecting, analysing and disseminating data on the occurrence of zoonoses, 
zoonotic agents and antimicrobial resistance related thereto (Directive 2003/99/EC) - conducting a 
planned sequence of observations or measurements with a view to obtaining an overview of the state 
of compliance with feed or food law, animal health and animal welfare rules
23. 
NUTS-3 area - The Nomenclature of Territorial Units for Statistics (in French: Nomenclature des 
unités  territoriales  statistiques)  (NUTS)  is  a  geocode  standard  for  referencing  the  subdivisions  of 
countries for statistical purposes. The NUTS regions are based on the existing national administrative 
subdivisions and there are three levels of NUTS defined. The current NUTS classification, valid from 
1 January 2012 until 31 December 2014, lists 97 regions at NUTS-1, 270 regions at NUTS-2 and 
1294 regions at NUTS-3 level. This category refers to regions belonging to the third level (NUTS-3), 
which is largely used by EUROSTAT and other European Union bodies. Depending on the size of the 
country, the NUTS-3 level may be a region, a county, a department, a group of municipalities etc. 
Random sample: It is a sample which is taken under statistical consideration to provide representative 
data
24. Random sampling is used to obtain a sample whose results can infer to the wider population. It 
is used to maximise external or ecological validity. 
                                                       
23   Regulation  (EC)  No 882/2004 of  the  European Parliament  and  of  the  Council of  29  April  2004  on  official  controls 
performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules, OJ L 
165, 30.4.2004, p. 1. Technical specifications on randomised sampling for AMR monitoring
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Retail: the handling and/or processing of food and its storage at the point of sale or delivery to the 
final consumer
25. In this document retail covers only shops, supermarkets and other similar outlets that 
sell  directly  to  the  final  consumer.  It  does  not  include  distribution  terminals  or  centres,  factory 
canteens, restaurants and other similar food service operations and wholesale outlets. 
Sample: ‘A subset of a population selected for inclusion in a study’ (Toma et al., 1999). In the 
framework of this document, samples from different matrices are collected and submitted to isolation 
of specific bacteria. 
Sampling:  ‘The  process  of  selecting  elements  from  a  population  in  order  to  construct  a  subset 
(sample) to be used for making inferences about the population’ (Toma et al., 1999).  
Sampling frame: ‘the assemblage of individuals (or groups) on which sampling is performed’ (Toma 
et al., 1999). 
Sampling frame: complete list of all units of the population which can be sampled. 
Sample size: the number of units randomly chosen from the sampling frame. 
Slaughter batch: for the purpose of this document, it represents a batch/lot of carcases slaughtered the 
same day and originating from the same flock of poultry or herd of pigs/bovines. 
Stratum/strata:  ‘Two  or  more  subsets  of  a  study  population  defined  by  mutually  exclusive 
characteristics’  (Toma  et  al.,  1999).  For  the  purpose  of  this  document,  strata  may  be  defined 
depending on the level at which sampling or collection of isolates is to be performed: i) in the case of 
isolates originating from samples collected at primary level, strata are represented by laboratories with 
available collections of isolates (considered separately per animal population of study); ii) in the case 
of isolates originating from samples collected (carcase samples) or to be collected (caecal samples) at 
slaughterhouse level, strata are represented by slaughterhouses; iii) in the case of isolates originating 
from samples to be collected at retail level, strata are represented by NUTS-3 regions. 
                                                                                                                                                                      
 
 
24   Commission Decision 98/179/EC of 23 February 1998 laying down detailed rules on official sampling for the monitoring 
of certain substances and residues thereof in live animals and animal products, OJ L 65, 5.3.1998, p. 31-34. 
25   Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety, OJ L 31, 1.2.2002, p. 1-24. Technical specifications on randomised sampling for AMR monitoring 
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ABBREVIATIONS 
AMR  Antimicrobial resistance 
CA  Competent Authority 
EC  European Commission 
EFSA   European Food Safety Authority 
EpiU  Epidemiological unit 
ESBL  Extended Spectrum Beta-Lactamase 
EU  European Union 
FBO  Food Business Operator 
MS  Member State 
NCP  National Control Programme 
NUTS  Nomenclature of territorial units for statistics 
SRS  Simple random sampling 
spp.  species 
 